This page shows Ucommune International Ltd (UK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Ucommune International Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Ucommune International Ltd has an operating margin of -155.5%, meaning the company retains $-156 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -29.9% the prior year.
Ucommune International Ltd's revenue declined 84.4% year-over-year, from $23.9M to $3.7M. This contraction results in a growth score of 0/100.
Ucommune International Ltd carries a low D/E ratio of 0.58, meaning only $0.58 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.
Ucommune International Ltd's current ratio of 1.07 is below the typical benchmark, resulting in a score of 16/100. However, the company holds substantial cash reserves (62% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.
While Ucommune International Ltd generated -$2.0M in operating cash flow, capex of $1.0M consumed most of it, leaving -$3.0M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Ucommune International Ltd generates a -6.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -79.2% the prior year.
Ucommune International Ltd passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Ucommune International Ltd generates $1.80 in operating cash flow (-$2.0M OCF vs -$1.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Ucommune International Ltd earns $-223.4 in operating income for every $1 of interest expense (-$5.8M vs $26K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Ucommune International Ltd generated $3.7M in revenue in fiscal year 2025. This represents a decrease of 84.4% from the prior year.
Ucommune International Ltd's EBITDA was -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.8% from the prior year.
Ucommune International Ltd reported -$1.1M in net income in fiscal year 2025. This represents an increase of 89.9% from the prior year.
Ucommune International Ltd earned $-0.07 per diluted share (EPS) in fiscal year 2025. This represents an increase of 99.1% from the prior year.
Cash & Balance Sheet
Ucommune International Ltd generated -$3.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 1967.1% from the prior year.
Ucommune International Ltd held $5.2M in cash against $0 in long-term debt as of fiscal year 2025.
Ucommune International Ltd had 4M shares outstanding in fiscal year 2025.
Margins & Returns
Ucommune International Ltd's gross margin was -2.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.9 percentage points from the prior year.
Ucommune International Ltd's operating margin was -155.5% in fiscal year 2025, reflecting core business profitability. This is down 125.6 percentage points from the prior year.
Ucommune International Ltd's net profit margin was -29.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 16.2 percentage points from the prior year.
Ucommune International Ltd's ROE was -6.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 73.1 percentage points from the prior year.
Capital Allocation
Ucommune International Ltd invested $1.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 53.5% from the prior year.
UK Income Statement
| Metric | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q1'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UK Balance Sheet
| Metric | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q1'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $43.5M-36.1% | $68.0M-17.8% | $82.6M-20.0% | $103.4M-31.3% | $150.5M-24.9% | $200.4M-31.8% | $293.9M-51.3% | $603.5M |
| Current Assets | $19.9M-41.8% | $34.2M-17.5% | $41.5M-2.7% | $42.7M-19.4% | $52.9M-1.3% | $53.6M-40.9% | $90.6M-22.9% | $117.6M |
| Cash & Equivalents | $12.4M+49.0% | $8.3M+8.7% | $7.6M-4.9% | $8.0M+4.1% | $7.7M-36.1% | $12.1M-53.6% | $26.0M-51.2% | $53.3M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $2.9M-70.0% | $9.8M-19.0% | $12.1M | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | $6.7M-97.1% | $235.0M |
| Total Liabilities | $23.8M-62.2% | $63.1M-13.4% | $72.9M-26.3% | $98.9M-29.0% | $139.3M-21.7% | $177.9M-24.2% | $234.6M-12.6% | $268.6M |
| Current Liabilities | $20.2M-61.9% | $52.9M-13.0% | $60.9M-24.3% | $80.4M-29.3% | $113.7M-8.6% | $124.4M-23.1% | $161.9M-7.2% | $174.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $13.8M+194.1% | $4.7M-46.1% | $8.7M+195.7% | $3.0M-60.3% | $7.4M-62.2% | $19.6M-62.8% | $52.8M-82.8% | $306.6M |
| Retained Earnings | -$631.6M0.0% | -$631.7M+1.2% | -$639.6M-1.4% | -$630.8M+3.9% | -$656.7M+1.5% | -$666.9M-0.3% | -$665.0M-93.7% | -$343.3M |
UK Cash Flow Statement
| Metric | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q1'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UK Financial Ratios
| Metric | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q1'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.99+0.3 | 0.65-0.0 | 0.68+0.2 | 0.53+0.1 | 0.47+0.0 | 0.43-0.1 | 0.56-0.1 | 0.67 |
| Debt-to-Equity | 1.72-11.7 | 13.40+5.1 | 8.35-25.1 | 33.49+14.7 | 18.74+9.7 | 9.05+4.6 | 4.44+3.6 | 0.88 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Ucommune International Ltd's annual revenue?
Ucommune International Ltd (UK) reported $3.7M in total revenue for fiscal year 2025. This represents a -84.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ucommune International Ltd's revenue growing?
Ucommune International Ltd (UK) revenue declined by 84.4% year-over-year, from $23.9M to $3.7M in fiscal year 2025.
Is Ucommune International Ltd profitable?
No, Ucommune International Ltd (UK) reported a net income of -$1.1M in fiscal year 2025, with a net profit margin of -29.6%.
What is Ucommune International Ltd's EBITDA?
Ucommune International Ltd (UK) had EBITDA of -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Ucommune International Ltd's gross margin?
Ucommune International Ltd (UK) had a gross margin of -2.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ucommune International Ltd's operating margin?
Ucommune International Ltd (UK) had an operating margin of -155.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ucommune International Ltd's net profit margin?
Ucommune International Ltd (UK) had a net profit margin of -29.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ucommune International Ltd's return on equity (ROE)?
Ucommune International Ltd (UK) has a return on equity of -6.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ucommune International Ltd's free cash flow?
Ucommune International Ltd (UK) generated -$3.0M in free cash flow during fiscal year 2025. This represents a -1967.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ucommune International Ltd's operating cash flow?
Ucommune International Ltd (UK) generated -$2.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ucommune International Ltd's total assets?
Ucommune International Ltd (UK) had $29.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ucommune International Ltd's capital expenditures?
Ucommune International Ltd (UK) invested $1.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Ucommune International Ltd's current ratio?
Ucommune International Ltd (UK) had a current ratio of 1.07 as of fiscal year 2025, which is considered adequate.
What is Ucommune International Ltd's debt-to-equity ratio?
Ucommune International Ltd (UK) had a debt-to-equity ratio of 0.58 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ucommune International Ltd's return on assets (ROA)?
Ucommune International Ltd (UK) had a return on assets of -3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ucommune International Ltd's cash runway?
Based on fiscal year 2025 data, Ucommune International Ltd (UK) had $5.2M in cash against an annual operating cash burn of $2.0M. This gives an estimated cash runway of approximately 31 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Ucommune International Ltd's Piotroski F-Score?
Ucommune International Ltd (UK) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ucommune International Ltd's earnings high quality?
Ucommune International Ltd (UK) has an earnings quality ratio of 1.80x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ucommune International Ltd cover its interest payments?
Ucommune International Ltd (UK) has an interest coverage ratio of -223.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Ucommune International Ltd?
Ucommune International Ltd (UK) scores 18 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.